Repligen to Report First Quarter 2026 Financial Results

Repligen (NASDAQ:RGEN) will report first quarter 2026 financial results on Tuesday, May 5, 2026.

Rhea-AI Summary

Repligen (NASDAQ:RGEN) will report first quarter 2026 financial results on Tuesday, May 5, 2026. The company will issue a press release before market open and host a conference call at 8:00 a.m. ET to discuss results for the quarter ended March 31, 2026.

The call is accessible via toll-free dial-ins, meeting ID 931163466, and a live webcast on the company Investor Relations website; a replay will be archived afterwards.

Argus Apr 22 session

-6.25% close to close Open Argus

Details

News Market Reaction – RGEN

In the Apr 22 session, RGEN declined 6.25%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -6.3% in the session following this news. A negative reaction to this scheduling upd...

Analysis

The stock moved -6.3% in the session following this news. A negative reaction to this scheduling update would contrast with the historically modest -0.36% move seen on a prior earnings-date notice. Such a decline could indicate broader concerns about the coming Q1 2026 release rather than the mechanics of the announcement itself. Earnings events can crystallize views on growth and margins, so positioning and risk management often become more cautious ahead of the call.

Key Figures

Earnings date: May 5, 2026 Quarter end date: March 31, 2026 Conference call time: 8:00 a.m. ET +3 more

Earnings date

May 5, 2026

Scheduled Q1 2026 financial results release before market open

Quarter end date

March 31, 2026

End of three-month reporting period for Q1 2026

Conference call time

8:00 a.m. ET

Time of Q1 2026 earnings conference call on May 5, 2026

Domestic dial-in

(833) 461-5787

Toll-free U.S. access number for the earnings call

International dial-in

(585) 542-9983

International access number for the earnings call

Meeting ID

931163466

Access code for the Q1 2026 earnings conference call

Previous Earnings date Reports

1 past event · Latest: Feb 10

Same Type 1 event

1. Feb 10

   Earnings date notice

   24h Move

   -0.4%

   Set date and call details for Q4 and full-year 2025 results.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Webcast and Conference Call to Be Held Tuesday, May 5, 2026, at 8:00 a.m. ET

WALTHAM, Mass., April 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2026 financial results on Tuesday, May 5, 2026. The Company will issue a press release before the market opens and will host a conference call at 8:00 a.m. ET to discuss business updates and financial results for the three-month reporting period ended March 31, 2026.

The conference call will be accessible by dialing toll-free (833) 461-5787 for domestic callers and (585) 542-9983 for international callers. The meeting ID is: 931163466. In addition, a webcast will be accessible via the Investor Relations section of the Company’s website. The webcast will be archived for a period of time following the live event. You can access the replay on the Investor Relations section of the Company’s website.

About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the Company see our website at www.repligen.com, and follow us on LinkedIn.

This press release may contain forward-looking statements within the meaning of the federal securities laws. Investors are cautioned that statements in this press release which are not strictly historical statements including, without limitation, statements identified by words like “believe,” “expect,” “may,” “will,” “should,” “seek,” or “could” and similar expressions, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including risks discussed from time to time in our filings with the Securities and Exchange Commission. We expressly disclaim any responsibility to update any forward-looking statements, except as required by law.

Repligen Contact:
Jacob Johnson
VP, Investor Relations
(781) 419-0204
investors@repligen.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Repligen (RGEN) report first quarter 2026 results?

Repligen will report Q1 2026 results on May 5, 2026 before the market opens. According to Repligen, a press release will be issued pre-market and a conference call will follow at 8:00 a.m. ET to discuss business updates and financial results.

How can investors join the Repligen (RGEN) earnings conference call on May 5, 2026?

Investors can join the conference call by dialing the provided toll-free numbers or via webcast on the Investor Relations site. According to Repligen, domestic dial-in is (833) 461-5787 and international is (585) 542-9983, meeting ID 931163466.

What time is the Repligen (RGEN) Q1 2026 conference call and what will it cover?

The conference call begins at 8:00 a.m. ET and will cover Q1 2026 results and business updates. According to Repligen, management will discuss financial results for the three-month period ended March 31, 2026 and related business developments.

Will Repligen (RGEN) provide a webcast or replay of the May 5, 2026 call?

Yes, a live webcast will be available and archived for later access on the Investor Relations website. According to Repligen, the webcast will be posted on the company Investor Relations section and a replay will be available afterwards.

What meeting ID is required to access the Repligen (RGEN) May 5, 2026 call?

The meeting ID for the May 5, 2026 call is 931163466. According to Repligen, callers should use that meeting ID when prompted after dialing the provided domestic or international numbers.

What period will Repligen (RGEN) discuss in its May 5, 2026 earnings call?

Repligen will discuss results for the quarter ended March 31, 2026 during the May 5, 2026 call. According to Repligen, the call and accompanying press release will cover financial results and business updates for that three-month period.